Youngevity International (NASDAQ:YGYI) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, November 13th.

Youngevity International (NASDAQ:YGYI) last posted its earnings results on Tuesday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. Youngevity International had a negative net margin of 6.26% and a negative return on equity of 79.57%. The business had revenue of $44.26 million for the quarter.

NASDAQ:YGYI opened at $8.42 on Friday. Youngevity International has a 1 year low of $3.17 and a 1 year high of $16.25. The company has a debt-to-equity ratio of 1.44, a current ratio of 0.93 and a quick ratio of 0.33.

Separately, Benchmark initiated coverage on shares of Youngevity International in a research note on Friday, August 10th. They issued a “buy” rating and a $7.00 target price on the stock.

TRADEMARK VIOLATION WARNING: “Youngevity International (YGYI) Scheduled to Post Quarterly Earnings on Tuesday” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at

About Youngevity International

Youngevity International, Inc develops and distributes health and nutrition related products and services through independent direct selling network in the United States and internationally. It operates in two segments, Direct Selling and Commercial Coffee. The company offers approximately 5,500 products, including nutritional, vitamin, mineral, herbal, liquid, and dietary supplements; apparel; fashion and jewelry accessories; digital products; and packaged foods.

Read More: Average Daily Trade Volume – What You Need to Know

Earnings History for Youngevity International (NASDAQ:YGYI)

Receive News & Ratings for Youngevity International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Youngevity International and related companies with's FREE daily email newsletter.